A new machine learning algorithm provides a ‘food processing score’ for every food on grocery store shelves, but will it lead to healthier eating? Medscape
Author: Medscape
HDL and Eye Disease: A Goldilocks Effect?
High and low levels of high-density lipoprotein and a novel single-nucleotide polymorphism were found to be associated with an increased risk for age-related macular degeneration. Medscape Medical News
Change Makers: Richard Francis on the Pillars of Innovation
One in every 13 prescriptions in the US is a generic from Teva. Now, CEO Richard Francis is focusing on drug development, delivering better medications faster. Medscape
High Dose Atropine Curbs Myopia in Kids Despite Side Effects
Children with myopia receiving 0.05% atropine showed less progression of the eye condition and axial elongation than those receiving placebo, according to 3-year results of the MOSAIC trial. Medscape Medical News
New Health Cybersecurity Rule: What Docs Should Know
A proposed federal rule would require hospitals and physicians’ groups to beef up health cybersecurity measures to protect patient privacy and prevent ransomware attacks. Some changes could be expensive, experts said. Medscape Medical News
Inventory System Supplier Settles Anti-Kickback Claim
A specialty pharmacy company agreed to a $1.67 million settlement that it gave inventory management systems to retina specialty practices for free in exchange for drug orders. Medscape Medical News
New Therapy Brings Hope for Dry AMD Vision Loss
The FDA has approved a first-of-its-kind treatment for dry age–related macular degeneration, a leading cause of blindness in adults over 55. WebMD Health News
Early Patching Benefits Kids Born With Cataract in One Eye
Consistent daily patching in the first year after surgery improved visual acuity in children with a congenital cataract in one eye, according to a post hoc analysis of the Infant Aphakia Treatment Study. Medscape Medical News
Dry January: Should Doctors Make It Year-Round?
Have sobering studies on alcohol caused physicians to drink less themselves or changed the way doctors counsel patients on booze? The answer is complicated. Medscape Medical News
Osteoporosis Medications Linked to Acute Angle Closure Risk
Patients with osteoporosis who took bisphosphonates, especially risedronate, were at a higher risk of developing acute angle closure, a recent study found. Medscape Medical News
Medscape 2050: The Future of Medicine
As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists to envision the future of medicine in the year 2050. Medscape
“I Had No Words”: The Patient Gifts Doctors Never Forget
These doctors were surprised and moved by very personal gifts given to them by grateful patients. Enjoy some good vibes this holiday season. Medscape
Study Finds Association Between Statins and Glaucoma
People with high cholesterol taking statins have a higher prevalence of glaucoma than those with elevated cholesterol but not taking the drug, a study found. Medscape Medical News
Novo’s Ozempic Faces Scrutiny Over Potential Link to Rare Eye Disease
Danish health authorities said on Monday they would ask the European Union’s drug regulator to review the findings of two Danish studies linking Novo Nordisk’s popular… Reuters Health Information
Viridian Shares Soar After Latest Trial Success for Thyroid Eye Disease Drug
Viridian Therapeutics’ experimental treatment for chronic thyroid eye disease (TED) significantly reduced symptoms such as double vision and eye bulging in a late-stage… Reuters Health Information
Oral Doxycycline Shows Promise in Ocular Syphilis Care
Oral doxycycline may be as effective as IV penicillin in treating ocular syphilis for some patients with the condition, a new study found. Medscape Medical News
Diabetes Drugs and Eye Disease: These Protect, These Don’t
Glucagon-like peptide 1 receptor agonists and fenofibrates may protect patients with type 2 diabetes against diabetic macular edema, a large-scale analysis of electronic medical records revealed. Medscape Medical News
Olaparib Protects Patients From High-Risk Cancer Recurrences
The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first patient in the phase 3 OlympiA trial was enrolled. Medscape Medical News
Eye Toxicities Are a Growing Concern With Certain ADCs
Some antibody-drug conjugates may cause such significant ocular toxicity that patients have vision damage or have to stop treatment, yet many oncologists are unaware of the risks, experts warned. Medscape Medical News
Empagliflozin May Slow Diabetic Retinopathy
Initiating empagliflozin vs a DPP-4 inhibitor may slow the progression of diabetic retinopathy in patients with type 2 diabetes and a history of nonproliferative diabetic retinopathy, a US-based cohort study found. Medscape Medical News